362
Views
7
CrossRef citations to date
0
Altmetric
ARTICLES

Clinical Differences Between Opioid Abuse Classes Ameliorated After 1 Year of Buprenorphine-Medication Assisted Treatment

, , &
Pages 100-111 | Published online: 27 Apr 2012

REFERENCES

  • Fischer , B , Patra , J , Cruz , M F , Gittins , J and Rehm , J . 2008 . Comparing heroin users and prescription opioid users in a Canadian multi-site population of illicit opioid users . Drug Alcohol Rev , 27 : 625 – 32 .
  • Wu , L T , Woody , G E , Yang , C and Blazer , D G . 2011 . How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on alcohol and related conditions . J Addict Med , 5 : 28 – 35 .
  • Room , R. 2005 . Stigma, social inequality and alcohol and drug use . Drug Alcohol Rev , 24 : 143 – 55 .
  • United Nations International Drug Control Program . 2005 . World Drug Report , Vienna : UNDCP .
  • Fischer , B and Rehm , J . 2007 . Illicit opioid use in the 21st century: witnessing a paradigm shift? . Addiction , 102 : 499 – 501 .
  • Boyce , N. 2011 . Health warnings for people who use heroin . Lancet , 377 : 193 – 4 .
  • Rosen , D , Hunsaker , A , Albert , S M , Cornelius , J R and Reynolds , C F 3rd . 2011 . Characteristics and consequences of heroin use among older adults in the United States: a review of the literature, treatment implications, and recommendations for further research . Addict Behav , 36 : 279 – 85 .
  • Fischer , B , Gittins , J and Rehm , J . 2008 . Characterizing the “awakening elephant” of prescription opioid misuse in North America: epidemiology, harms, interventions . Contemporary Drug Problems , 35 : 397 – 426 .
  • Zacny , J , Bigelow , G , Compton , P , Foley , K , Iguchi , M and Sannerud , C . 2003 . College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement . Drug Alcohol Depend , 69 : 215 – 32 .
  • Compton , W M and Volkow , N D . 2006 . Major increases in opioid analgesic abuse in the United States: concerns and strategies . Drug Alcohol Depend , 81 : 103 – 7 .
  • Sigmon , S C . 2006 . Characterizing the emerging population of prescription opioid abusers . Am J Addict , 15 : 208 – 12 .
  • Kuehn , B M . 2007 . Opioid prescriptions soar: increase in legitimate use as well as abuse . JAMA , 297 : 249 – 51 .
  • Manchikanti , L. 2007 . National drug control policy and prescription drug abuse: facts and fallacies . Pain Physician , 10 : 399 – 424 .
  • Substance Abuse and Mental Health Service Administration . 2003 . “ Results from the 2002 National Survey on Drug Use and Health: National Findings ” . Rockville , MD (Office of Applied Studies, NHSDA Series H–22, DHHS Publication No. SMA 03–3836)
  • Birnbaum , H G , White , A G , Schiller , M , Waldman , T , Cleveland , J M and Roland , C L . 2011 . Societal costs of prescription opioid abuse, dependence, and misuse in the United States . Pain Med , 12 : 657 – 67 .
  • Darke , S , Topp , L and Ross , J . 2002 . The injection of methadone and benzodiazepines among Sydney injecting drug users 1996–2000: 5-year monitoring of trends from the Illicit Drug Reporting System . Drug Alcohol Rev , 21 : 27 – 32 .
  • Johnson , R E and McCagh , J C . 2000 . Buprenorphine and naloxone for heroin dependence . Curr Psychiatry Rep , 2 : 519 – 26 .
  • Connock , M , Juarez-Garcia , A Jowett , S . 2007 . Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation . Health Technol Assess , 11 : 1 – 171 .
  • Mattick , R P , Kimber , J , Breen , C and Davoli , M . 2008 . Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence . Cochrane Database Syst Rev , CD002207
  • Soyka , M , Zingg , C , Koller , G and Kuefner , H . 2008 . Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study . Int J Neuropsychopharmacol , 11 : 641 – 53 .
  • Maremmani , I , Pani , P P , Pacini , M and Perugi , G . 2007 . Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted pa- tients . J Subst Abuse Treat , 33 : 91 – 8 .
  • Kamien , J B , Branstetter , S A and Amass , L . 2008 . Buprenorphine-naloxone versus metha- done maintenance therapy: a randomised double-blind trial with opioid-dependent patients . Heroin Addiction and Related Clinical Problems , 10 : 5 – 18 .
  • Magura , S , Lee , J D Hershberger , J . 2009 . Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial . Drug Alcohol Depend , 99 : 222 – 30 .
  • Moore , B A , Fiellin , D A Barry , D T . 2007 . Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients . J Gen Intern Med , 22 : 527 – 30 .
  • Center for Substance Abuse Treatment . 2004 . Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, MD: Substance Abuse and Mental Health Services Administration .
  • Ruetsch , C , Cacciola , J and Tkacz , J . 2010 . A national study of a telephonic support service for patients receiving office-based buprenorphine medication asstisted treatment: study feasibility and sample description . J Subs Abuse Treat , 39 : 307 – 17 .
  • Netherland , J , Botsko , M Egan , J E . 2009 . Factors affecting willingness to provide buprenorphine treatment . J Subst Abuse Treat , 36 : 244 – 51 .
  • McLellan , A T , Cacciola , J C , Alterman , A I , Rikoon , S H and Carise , D . 2006 . The Addiction Severity Index at 25: origins, contributions and transitions . Am J Addict , 15 : 113 – 24 .
  • McLellan , A T , Kushner , H Metzger , D . 1992 . The fifth edition of the Addiction Severity Index . J Subst Abuse Treat , 9 : 199 – 213 .
  • Zanis , D A , McLellan , A T , Cnaan , R A and Randall , M . 1994 . Reliability and validity of the Addiction Severity Index with a homeless sample . J Subst Abuse Treat , 11 : 541 – 8 .
  • Zanis , D A , McLellan , A T and Corse , S . 1997 . Is the Addiction Severity Index a reliable and valid assessment instrument among clients with severe and persistent mental illness and substance abuse disorders? . Community Ment Health J , 33 : 213 – 27 .
  • Brodey , B B , Rosen , C S , Brodey , I S , Sheetz , B M , Steinfeld , R R and Gastfriend , D R . 2004 . Validation of the Addiction Severity Index (ASI) for internet and automated telephone self-report administration . J Subst Abuse Treat , 26 : 253 – 9 .
  • Satre , D D , Mertens , J R , Arean , P A and Weisner , C . 2004 . Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program . Addiction , 99 : 1286 – 97 .
  • Cramer , J , Rosenheck , R , Kirk , G , Krol , W and Krystal , J . 2003 . Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes . Value Health , 6 : 566 – 73 .
  • Dole , V P and Nyswander , M E . 1976 . Methadone maintenance treatment. A ten-year perspective . JAMA , 235 : 2117 – 9 .
  • Joseph , H , Stancliff , S and Langrod , J . 2000 . Methadone maintenance treatment (MMT): a review of historical and clinical issues . Mt Sinai J Med , 67 : 347 – 64 .
  • Tkacz , J , Severt , J , Cacciola , J and Ruetsch , C . 2012 . Compliance with buprenorphine-medication assisted treatment and relapse to opioid use . Am J Addict. , 21 : 55 – 62 . doi: 10.1111/j.1521–0391.2011.00186.x
  • Wilford , BB and Maxwell , JC . 2006 . Diversion and abuse of buprenorphine: a brief assessment of emerging indicators . : 1 – 70 . In: SAMHSA, ed. Division of pharmacologic therapies. Washington, DC: US Department of Health & Human Services
  • Alho , H , Sinclair , D , Vuori , E and Holopainen , A . 2007 . Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users . Drug Alcohol Depend , 88 : 75 – 8 .
  • Feroni , I , Peretti-Watel , P Paraponaris , A . 2005 . French general practitioners’ attitudes and prescription patterns toward buprenorphine maintenance treatment: does doctor shopping reflect buprenorphine misuse? . J Addict Dis , 24 : 7 – 22 .
  • Inciardi , J A , Surratt , H L , Cicero , T J , Kurtz , S P , Martin , S S and Parrino , M W . 2009 . The “black box” of prescription drug diversion . J Addict Dis , 28 : 332 – 47 .
  • Jena , A B and Goldman , D P . 2011 . Growing internet use may help explain the rise in prescription drug abuse in the United States . Health Aff (Millwood) , 30 : 1192 – 9 .
  • Fiellin , D A , Kleber , H , Trumble-Hejduk , J G , McLellan , A T and Kosten , T R . 2004 . Consensus statement on office-based treatment of opioid dependence using buprenorphine . J Subst Abuse Treat , 27 : 153 – 9 .
  • Becker , W C , Tobin , D G and Fiellin , D A . 2011 . Nonmedical use of opioid analgesics obtained directly from physicians: prevalence and correlates . Arch Intern Med , 171 : 1034 – 6 .
  • Del Boca , F K and Noll , J A . 2000 . Truth or consequences: the validity of self-report data in health services research on addictions . Addiction , 95 ( Suppl 3 ) : S347 – 60 .
  • Darke , S. 1998 . Self-report among injecting drug users: a review . Drug Alcohol Depend , 51 : 253 – 63 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.